Institution
Azienda Ospedaliera Citta' della Salute e della Scienza di Torino
- 3running trials
- 9closed trials
- 13,549publications (OpenAlex)
Running trials
Recruiting
SILibinin in NSCLC and BC Patients With Single Brain METastasis (SILMET)
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Brain metastases1 recruiting
- Lung cancer1 recruiting
Closed trials
Completed
Completed
A Study of Pulmonary Arterial Hypertension Participants Treated With Macitentan or Selexipag
Completed
Completed
Terminated
Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma
Completed
Completed
Completed
Completed
Registry name variants (2)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Azienda Ospedaliera Città della Salute e della Scienza di Torino
Torino, 10126
10 trials
Azienda Ospedaliera Città della Salute e della Scienza di Torino
Turin, 10126
2 trials
NCT05689619SILibinin in NSCLC and BC Patients With Single Brain METastasis (SILMET)
Contact: Alessia Pellerino, M.D., Ph.D
Conditions
Diseases this institution publishes on or runs trials for.
- Multiple myeloma38 works · 0 trials
- ALS (motor neurone disease)18 works · 0 trials
- Ventricular tachycardia15 works · 0 trials
- Macular degeneration12 works · 0 trials
- Myocarditis11 works · 0 trials
- Myeloproliferative neoplasms10 works · 0 trials
- Pulmonary arterial hypertension10 works · 1 trial
- Haemophilia9 works · 0 trials
- Chronic lymphocytic leukaemia9 works · 1 trial
- Mantle cell lymphoma9 works · 1 trial
- Psoriatic arthritis9 works · 1 trial
- Meningioma8 works · 0 trials
- Mesothelioma6 works · 0 trials
- Lewy body dementia5 works · 0 trials
Institution data: ROR 001f7a930 (CC0-1.0)Updated 15 Nov 2026